Search Results
Found 2 results
510(k) Data Aggregation
(158 days)
Endoscopic Camera System
Endoscopic Camera System is a camera control unit (CCU) for use with camera heads and video endoscopes for visualization, image recording and documentation during general endoscopic and microscopic procedures.
The device consists of a camera control unit (CCU) and a camera head.
The device is intended to be used to connect with an optical endoscope during the endoscopic diagnosis and/or treatment/surgery, and to capture, process and transmit images in the human body cavity under the field of view observed by the endoscope to the monitor.
There are 4 models of the device. The hardware configuration of the device of 4 models are same, and difference is different functions which opened up through software.
The provided FDA 510(k) clearance letter describes an Endoscopic Camera System (K250204) and its substantial equivalence to a predicate device (Image1 SPIES System, K160044). However, it does not provide detailed acceptance criteria or the specific results of a study (e.g., clinical study) that quantitatively proves the device meets strict performance thresholds.
The letter primarily focuses on the device's technical specifications and compliance with non-clinical performance tests relevant to the safety and fundamental function of an endoscopic camera system. It highlights that the device "met all its specifications" and that bench tests demonstrated the device's characteristics have been met, but it does not specify what those specifications or characteristics are in measurable terms related to clinical performance.
Based on the provided text, here's an attempt to answer your questions, highlighting what is available and what is explicitly missing:
1. Table of Acceptance Criteria and Reported Device Performance
The document states: "The bench test data for the Endoscopic Camera System demonstrates that the design characteristics used as the basis for the comparison have been met. The results show that the subject device has met all its specifications." and "The bench testing performed verified and validated that the Endoscopic Camera System has met all its design specification and is substantially equivalent to the predicate device, Image1 SPIES System."
However, the specific acceptance criteria (measurable thresholds) and the quantitative reported device performance for these specifications are NOT detailed in this public FDA 510(k) clearance letter.
The letter mentions "minor technology differences" in:
- Horizontal resolution
- Spatial frequency response
- Field of view
- Focal length
- Dimensions
- Weight of camera head
- Image delay
- Video output
- USB port of CCU
For these parameters, the letter ambiguously states that these differences "does not raise new issues of safety and effectiveness." It implies that the new device's performance for these characteristics is either equivalent or acceptably different without introducing new risks compared to the predicate, but specific numbers are not provided.
Acceptance Criteria (Example/Inferred) | Reported Device Performance (Not Provided Quantitatively in Letter) |
---|---|
Horizontal Resolution = [X] | Met specification, equivalent to predicate K160044 |
Spatial Frequency Response = [Y] | Met specification, equivalent to predicate K160044 |
Field of View = [Z] | Met specification, equivalent to predicate K160044 |
Focal Length = [A] | Met specification, equivalent to predicate K160044 |
Image Delay |
Ask a specific question about this device
(70 days)
KARL STORZ ENDOVISION XL ENDOSCOPIC CAMERA SYSTEM
The Karl Storz Imaging (KSI) Endovision XL System is a color, television camera head designed for use with any flexible or rigid endoscope. The camera head may be attached to any rigid or flexible endoscope, such as sinoscopes, colonoscopes, sigmoidoscopes, bronchoscopes, gastroscopes, laparoscopes, choledoscopes, ureteroscopes, hysteroscopes and arthroscopes. The camera is connected to the video processor via a ten foot cable. The endoscopic image can be displayed on any standard operating room video monitor.
The Endovision XL is a state-of-the-art endoscopic camera. The head of the camera is equipped with a V-mount thread, allowing the head to couple to Karl Storz V-mount optical adapters. Three adapters, 15 mm, 20 mm and 25 mm, are available with the system. These couplers allow easy attachment of the XL head to any standard endoscope. Microprocessor controlled automatic exposure adjusts image brightness. The image sensor is a 1/4" CCD-chip. The processor weighs 1.77 pounds and the camera .6 pounds. Dimensions of the processor and camera in width, height and depth are: 8.29 x 2.16 x 6.07 inches and 1.96 x 2.4 x 3.9 inches respectively.
This 510(k) summary (K974391) describes an endoscopic camera system. It does not contain the detailed performance study information typically associated with establishing acceptance criteria and proving a device meets them through clinical or technical studies.
Here's an analysis based on the provided text, highlighting what is not present:
1. Table of Acceptance Criteria and Reported Device Performance:
The document does not provide a table of acceptance criteria or specific reported device performance metrics. The submission focuses on substantial equivalence to previously cleared devices rather than new performance claims that would require specific acceptance criteria and detailed quantitative results.
2. Sample size used for the test set and the data provenance:
Not applicable. The document does not describe a test set or explicit performance data from a study. The basis for clearance is substantial equivalence to existing devices.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
Not applicable. No ground truth establishment is described for a test set.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:
Not applicable. No adjudication method is described.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done:
No, an MRMC comparative effectiveness study was not done or described in this document. The focus is on the device's physical characteristics being "smaller, lighter, more portable" compared to its predicates.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
Not applicable. This device is a camera system, not an algorithm. Its performance is inherent in its image capture capabilities, which are established by equivalence.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):
Not applicable. No ground truth is described.
8. The sample size for the training set:
Not applicable. This is not an AI/algorithm-based device requiring a training set.
9. How the ground truth for the training set was established:
Not applicable. This is not an AI/algorithm-based device.
Summary of the Study per the Provided Document:
The provided document (a 510(k) summary) does not describe a formal study with acceptance criteria and a detailed performance evaluation. Instead, the "study" (or rather, the justification for marketing) is based on the concept of Substantial Equivalence.
- Substantial Equivalence Claim: Karl Storz Imaging (KSI) states that its "Endovision XL endoscopic camera system is substantially equivalent to several other systems currently on the market including the KSI Tricam Color Endoscopic Television System (K950862) and the KSI Telecam Color Endoscopic Television System (K883943)."
- Basis for Equivalence: The document explicitly states, "The proposed new KSI Endovision XL is unique only in that it is a smaller, lighter, more portable camera system." This implies that its core functional performance (e.g., image quality, illumination, compatibility with endoscopes) is considered comparable or identical to the predicate devices, with the primary difference being size and weight for improved portability.
- FDA Response: The FDA's letter confirms their review and determination that "the device is substantially equivalent...to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified..." This indicates the FDA agreed with the substantial equivalence claim based on the information provided, without requiring a new, specific performance study with acceptance criteria for this particular submission.
Ask a specific question about this device
Page 1 of 1